2021
DOI: 10.1016/j.oraloncology.2021.105588
|View full text |Cite
|
Sign up to set email alerts
|

Liquid biopsy = Individualized cancer management: Diagnosis, monitoring treatment and checking recurrence and metastasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 25 publications
0
5
0
Order By: Relevance
“…Over the past few decades, exosome-based liquid biopsies have received much attention from clinicians and scientists, with the advantages of easy access, convenience, non-invasiveness, time and effort savings, high reliability, reproducibility, ease of early detection, low cost, and high benefit. 37 They can also track and monitor tumour progression and drug resistance in real time allowing for continuous sampling to provide information on tumour heterogeneity, 114 making it an ideal method for early screening and diagnosis of oral cancer. Figure 2 provides a summary of exosomes as a source of biomarkers for oral cancer diagnosis.…”
Section: Current Status Of Research On Exosomes In the Diagnosis And ...mentioning
confidence: 99%
“…Over the past few decades, exosome-based liquid biopsies have received much attention from clinicians and scientists, with the advantages of easy access, convenience, non-invasiveness, time and effort savings, high reliability, reproducibility, ease of early detection, low cost, and high benefit. 37 They can also track and monitor tumour progression and drug resistance in real time allowing for continuous sampling to provide information on tumour heterogeneity, 114 making it an ideal method for early screening and diagnosis of oral cancer. Figure 2 provides a summary of exosomes as a source of biomarkers for oral cancer diagnosis.…”
Section: Current Status Of Research On Exosomes In the Diagnosis And ...mentioning
confidence: 99%
“…Characterized, therapeutically relevant ctDNA alterations can also be found in CCA patients after gene-targeted therapy[ 13 ]. Furthermore, since ctDNA may include DNA shed into the bloodstream from both primary and metastatic tumours, the genomic alterations of ctDNA can reflect the cancer heterogeneity of the whole body better than those found in tissue biopsy[ 14 , 15 ]. Cancer heterogeneity may be part of the reason for the unfavourable outcomes of several gene-targeted trials in CCA[ 16 ].…”
Section: To the Editormentioning
confidence: 99%
“… 62 , 63 Exosomes can track and monitor tumor progression and drug resistance in real-time giving information on drug heterogeneity. 64 A proteome map of human parotid exosomes has also been developed using multi-dimensional protein identification technology, which helps in discovering exosome protein markers related to oral cancer. 65 …”
Section: Introductionmentioning
confidence: 99%